Dabur India Ltd Quarterly Results

Dabur has accused FSSAI of favouring other manufacturers over its restrictions on "100 per cent" claims on food products

The court said Dabur should have been heard before the directive was issued; the company warned that compliance could affect products worth more than ₹150 crore

Gaurang Shah of Geojit Financial Services said that Dabur has been in the market for a long time, has a good amount of goodwill for its products and an unmatched product portfolio.

Dabur has moved the Delhi High Court against an FSSAI order directing it to stop selling food products carrying "100%" claims. The matter is likely to be heard on Friday

From misleading labels and '100%' purity claims to liquor, nutraceuticals, packaged water and quick commerce, here's a look at FSSAI's recent enforcement actions

The US Food and Drug Administration (USFDA) has issued a warning letter to home-grown FMCG major Dabur India citing significant violations of current good manufacturing practices (CGMP) at its pharmaceutical manufacturing facility in Silvassa. The warning letter follows an inspection conducted by the US health regulator at the company's facility in Silvassa, Dadra and Nagar Haveli and Daman and Diu, from January to December 16, 2026. USDFA, in its letter dated July 24, 2027, to Dabur India CEO Mohit Malhotra, has pointed out data integrity lapses, inadequate quality oversight and deficient manufacturing controls. According to the USFDA, the facility's methods, controls and manufacturing practices did not conform to CGMP requirements, resulting in the products being considered "adulterated" under the US Federal Food, Drug and Cosmetic Act. Among the most serious findings, the USFDA said its investigator discovered that an equipment usage logbook provided by the company for a ...

The FMCG major said it is engaging with the food regulator after it barred the sale of products carrying '100 per cent' claims and sought an action taken report.

According to reports, the food regulator FSSAI has prohibited Dabur India from selling many products such as honey, cow ghee, and edible oils using '100%' claims; BSE seeks clarification.

Food regulator FSSAI has prohibited Dabur India from selling many products such as honey, cow ghee, and edible oils using '100 per cent' claims, saying that such labelling is against the law. In a social media post on Monday, Food Safety and Standards Authority of India (FSSAI) informed that it has issued a prohibition order to Dabur India Ltd over the sales of food products carrying misleading '100 per cent' claims, including honey, apple cider vinegar, virgin coconut oil, sesame oil, cow ghee, coconut water, coconut milk and other such items. Giving details about the violations, the FSSAI said that "food products being sold on the company's website were found carrying misleading '100%' claims such as '100% Natural', '100% Pure', '100% Purity Guaranteed', '100% Organic' and '100% Tender Coconut Water'." The regulator asserted that the use of the 100 per cent claims is in contravention of the FSS (Advertising & Claims) Regulations, 2018, as they are ambiguous, unverifiable and ...

Bharti Airtel, BSE, Deepak Nitrite, Godrej Properties, Emami, Kalyan Jewellers, MCX, Marico, Nykaa, ONGC, PNB Housing and UBL among key companies slated to post their earnings today.